刘瑞

研究领域(方向):

细胞膜色谱技术

过敏性鼻炎的生物标志物分析

靶向肥大细胞的抗过敏中药活性分子筛选及其作用机制研究

个人及工作简历(个人受教育及工作经历):

2020-11至今西安交通大学,药学院,副教授

2018-07至2020-10 西安交通大学,药学院,助理研究员

2017-07至2017-12 约翰·霍普金斯大学,医学院,实习生

2016-01至2016-06 约翰·霍普金斯大学,医学院,实习生

2012-09至2018-06 西安交通大学,药物分析学,医学博士

2008-09至2012-07 西安交通大学,制药工程,工学学士

主要科研项目

[1]国家自然科学基金委员会,青年科学基金项目,81903572,基于MRGPRX2的盐酸青藤碱代谢物类过敏成分筛选分析基础研究,2020-01至2022-12,21万元,结题,主持

[2]中国博士后科学基金会,博士后科学基金面上二等,2019M663755,细胞膜色谱用于筛选苍耳子中抗类过敏天然活性成分研究,2019-01至2020-12,8万元,结题,主持

[3]榆林市科技局,市级重要项目子课题,YF-ZDZX-01-ZKT03,榆林季节性过敏的治疗与防控研究,2024-01至2024-12,100万元,结题,主持

学术及科研成果、专利、论文

代表性学术论文:

[1]Chao Wang1, Na Wang2, Ling Gong, Hongfen Du, Shiqiong Luo, Xiaolan Ji, Yujuan Yuan, Yuanyuan Ding, Xukai Guan,Rui Liu#,Tao Zhang#. Plasma MRGPRX2 Correlates with Severity of Artemisia-Induced Allergic Rhinitis, Particularly in IgE-Negative Patients: A Cross-Sectional Study, Journal of Asthma and Allergy, 2025, 18:1761-1772.

[2]Yihan Huang, Na Wang, Xiaolan Ji, Shiqiong Luo, Ling Gong, Chenrui Zhao, Guodong Zheng,Rui Liu#, Tao Zhang#. Apigenin ameliorates inflamed ulcerative colitis by regulating mast cell degranulation via the PAMP-MRGPRX2 feedback loop, Phytomedicine, 2025, 140: e156564.

[3]Youfa Qin, Yihan Huang, Xiaolan J, Ling Gong, Shiqiong Luo, Jiapan Gao,Rui Liu#, Tao Zhang#. N-demethylsinomenine metabolite and its prototype sinomenine activate mast cells via MRGPRX2 and aggravate anaphylaxis, Frontiers in Pharmacology, 2024, 15:1389761.

[4]Yonghui Zhang, Yihan Huang, Baowen Dang, Shiting Hu, Chenrui Zhao, Yuejin Wang, Yujuan Yuan,Rui Liu#. Fisetin alleviates chronic urticaria by inhibiting mast cell activation via MRGPRX2, Journal of Pharmacy and Pharmacology, 2023 Oct 5;75(10):1310-1321.

[5]Rui Liu, Yonghui Zhang, Yuejin Wang, Yihan Huang, Jiapan Gao, Xi Tian, Tianyou Ma, Tao Zhang*. Anti‐inflammatory effect of dictamnine on allergic rhinitis via suppression of the LYN kinase‐mediated molecular signaling pathway during mast cell activation, Phytotherapy Research, 2023, 37(9): 4236-4250.

[6]Jiapan Gao, Yuanyuan Ding, Yuejin Wang, Peida Liang, Liyang Zhang,Rui Liu#. Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography. Phytotherapy Research, 2021, 35(6):3194-3204.

[7]Chuchu Qiao, Shiling Hu, Delu Che, Jue Wang, Jiapan Gao, Ruiping Ma, Wenjun Jiang, Tao Zhang,Rui Liu*. The anti-anaphylactoid effects of Piperine through regulating MAS-related G protein-coupled receptor X2 activation, Phytotherapy Research, 2020, 34(6): 1409-1420.

[8]Rui Liu, Shiling Hu, Yuanyuan Ding, Jue Wang, Yuejin Wang, Jiapan Gao, Langchong He. Dictamnine is an effective anti-anaphylactoid compound acting via the MrgX2 receptor located on mast cells, Phytotherapy Research, 2021, 35(6):3181-3193.

[9]Rui Liu, Tingting Zhao, Delu Che, Jiao Cao, Jue Wang, Yanni Lv, Pengyu Ma, Yuanyuan Ding, Nana Wang, Xiaoyang Wang, Nan Wang, Jianli Wang, Zijun Gao, Tao Zhang*. The anti-anaphylactoid effects of hydroxysafflor yellow A on the suppression of mast cell Ca2+influx and degranulation, Phytomedicine, 2018, 48: 43-50.

[10]Rui Liu, Delu Che, Tingting Zhao, Priyanka Pundir, Jiao Cao, Yanni Lv, Jue Wang, Pengyu Ma, Jia Fu, Nana Wang, Xiaoyang Wang, Tao Zhang, Xinzhong Dong, Langchong He*. MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions, Biochemical Pharmacology, 2017, 146: 214-223.

代表性专利:

[1]张涛,丁园园,刘瑞,贺浪冲,王楠,马维娜,李超美.一种用于制备ELISA鼠单克隆包被抗体和兔检测抗体的多肽及其应用, ZL 2019 1 0468919.6, 2021年05月28日.

[2]贺浪冲,王楠,张涛,丁园园,刘瑞,韩省力.一种用于制备类过敏反应的双抗夹心试剂盒体的多肽及其应用, ZL 2019 1 0468926.6, 2021年05月28日.

[3]张涛,丁园园,刘瑞,贺浪冲,马维娜,韩省力.一种对类过敏反应特异性受体MRGPRX2蛋白的具有免疫原性的多肽及其应用, ZL 2019 1 0468920.9, 2021年05月28日.

[4]刘瑞,马维娜,贺浪冲,丁园园,张涛,曹娇,李超美.一种用于制备兔多克隆抗体的多肽及其应用, ZL 2019 1 0469462.0, 2021年04月20日.

[5]贺浪冲,韩省力,张涛,丁园园,刘瑞,王楠.一种抗Mrgprx2抗体的优势抗原表位多肽及其应用, ZL 2019 1 0469478.1, 2021年04月20日.

联系方式

电子邮箱:rliu2018@xjtu.edu.cn

联系电话18092186746

个人主页:https://gr.xjtu.edu.cn/web/rliu2018

联系地址:西安交通大学创新港校区21号楼5106办公室


下一篇:苏琪

地址:陕西省西安市咸宁西路28号 邮编:710049
版权所有:西安交通大学 站点建设与维护: 网络信息中心 陕ICP备06008037号